3 hr 58 min
How OpenEvidence Became a $12 Billion AI Healthcare Giant
The full story of OpenEvidence, from founder Daniel Nadler selling Kensho to S&P Global for $550 million to building a clinical decision support tool that now handles about 358,000 physician queries a day. Covers the technical architecture, the Mayo Clinic partnership, the USMLE 100% score debate, the funding rounds from Series A through D, and the move into AI scribing and DeepConsult.
Watch on YouTube